During tumor lymphangiogenesis, tumor-associated macrophages (TAMs) release VEGF-C/D, which increases tumor lymphangiogenesis by interacting with their receptor VEGFR3 on lymphatic endothelial cells (LECs) (43, 44). The gene discussed is FLT4; the disease is neoplasm.